Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

Therapeutics and Clinical Risk Management


Archive: Volume 4, 2008


Treating oligohydramnios with extract of Salvia miltiorrhiza: A randomized control trial

Hong-nü Chu, Mei-juan Shen

Therapeutics and Clinical Risk Management 2008, 4:287-290

Published Date: 8 February 2008

Factors affecting therapeutic compliance: A review from the patient’s perspective

Jing Jin, Grant Edward Sklar, Vernon Min Sen Oh, Shu Chuen Li

Therapeutics and Clinical Risk Management 2008, 4:269-286

Published Date: 8 February 2008

Zoledronic acid in the management of metastatic bone disease

Thomas J Polascik, Vladimir Mouraviev

Therapeutics and Clinical Risk Management 2008, 4:261-268

Published Date: 8 February 2008

Cannabinoids in the management of difficult to treat pain

Ethan B Russo

Therapeutics and Clinical Risk Management 2008, 4:245-259

Published Date: 8 February 2008

A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)

Lala M Dunbar, Derek M Tang, Robert M Manausa

Therapeutics and Clinical Risk Management 2008, 4:235-244

Published Date: 8 February 2008

Management of laryngopharyngeal reflux with proton pump inhibitors

Christina Reimer, Peter Bytzer

Therapeutics and Clinical Risk Management 2008, 4:225-233

Published Date: 8 February 2008

Therapeutical approach to plasma homocysteine and cardiovascular risk reduction

Marcello Ciaccio, Giulia Bivona, Chiara Bellia

Therapeutics and Clinical Risk Management 2008, 4:219-224

Published Date: 8 February 2008

A review of topotecan in combination chemotherapy for advanced cervical cancer

Minoo Robati, David Holtz, Charles J Dunton

Therapeutics and Clinical Risk Management 2008, 4:213-218

Published Date: 8 February 2008

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)

Martin Henkes, Heiko van der Kuip, Walter E Aulitzky

Therapeutics and Clinical Risk Management 2008, 4:163-187

Published Date: 8 February 2008

Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate

Omar S Din, Penella J Woll

Therapeutics and Clinical Risk Management 2008, 4:149-162

Published Date: 8 February 2008

Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris

Efstratios Vakirlis, Athanasios Kastanis, Demetrios Ioannides

Therapeutics and Clinical Risk Management 2008, 4:141-148

Published Date: 8 February 2008

A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma

Teru Hideshima, Noopur Raje, Paul G Richardson, Kenneth C Anderson

Therapeutics and Clinical Risk Management 2008, 4:129-136

Published Date: 8 February 2008

A review of solifenacin in the treatment of urinary incontinence

Ramandeep Basra, Con Kelleher

Therapeutics and Clinical Risk Management 2008, 4:117-128

Published Date: 8 February 2008

Trabectedin and its potential in the treatment of soft tissue sarcoma

Philippe A Cassier, Armelle Dufresne, Jean-Yves Blay, Jérôme Fayette

Therapeutics and Clinical Risk Management 2008, 4:109-116

Published Date: 8 February 2008

A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting

Mark A Ware, Paul Daeninck, Vincent Maida

Therapeutics and Clinical Risk Management 2008, 4:99-107

Published Date: 8 February 2008

Advances in the use of topical imiquimod to treat dermatologic disorders

Francesco Lacarrubba, Maria Rita Nasca, Giuseppe Micali

Therapeutics and Clinical Risk Management 2008, 4:87-97

Published Date: 8 February 2008

Anidulafungin in the treatment of invasive fungal infections

Kathryn Sabol, Tawanda Gumbo

Therapeutics and Clinical Risk Management 2008, 4:71-78

Published Date: 8 February 2008

Why does the world need another rotavirus vaccine?

Richard L Ward, Monica M McNeal, A Duncan Steele

Therapeutics and Clinical Risk Management 2008, 4:49-63

Published Date: 8 February 2008

Serotonin receptor modulators in the treatment of irritable bowel syndrome

Mohammad Fayyaz, Jeffrey M Lackner

Therapeutics and Clinical Risk Management 2008, 4:41-48

Published Date: 8 February 2008

Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review

Jason W Bennett, James S Lewis II, Michael W Ellis

Therapeutics and Clinical Risk Management 2008, 4:31-40

Published Date: 8 February 2008

Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy

Mischel G Neill, Rohan Shahani, Alexandre R Zlotta

Therapeutics and Clinical Risk Management 2008, 4:11-18

Published Date: 8 February 2008

Review of photodynamic therapy in actinic keratosis and basal cell carcinoma

Marica B Ericson, Ann-Marie Wennberg, Olle Larkö

Therapeutics and Clinical Risk Management 2008, 4:1-9

Published Date: 8 February 2008

Editorial ||FREE PAPER||

Garry M Walsh

Therapeutics and Clinical Risk Management 2008, 4:0-0

Published Date: 8 February 2008